SEC Form 4 · accession 0001290473-16-000099
EQUINIX INC · EQIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sara Baack
Officer — Chief Marketing Officer
Period of report
Feb 16, 2016
Accepted (ET)
Feb 18, 2016 · 8:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101239
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 16, 2016 | M | 267 | $0.00 | A | 9,722 | D | |
| Common Stock | Feb 16, 2016 | M | 1,429 | $0.00 | A | 11,151 | D | |
| Common StockF2 | Feb 16, 2016 | S | 500 | $285.266 | D | 10,651 | D | |
| Common StockF3 | Feb 16, 2016 | S | 400 | $285.9575 | D | 10,251 | D | |
| Common Stock | Feb 16, 2016 | S | 100 | $286.84 | D | 10,151 | D | |
| Common Stock | Feb 16, 2016 | S | 100 | $288.15 | D | 10,051 | D | |
| Common StockF4 | Feb 16, 2016 | S | 1,751 | $289.8624 | D | 8,300 | D | |
| Common StockF5 | Feb 17, 2016 | S | 79 | $287.6063 | D | 8,221 | D | |
| Common StockF6 | Feb 17, 2016 | S | 261 | $288.5013 | D | 7,960 | D | |
| Common StockF7 | Feb 17, 2016 | S | 1,056 | $290.4583 | D | 6,904 | D | |
| Common Stock | Feb 17, 2017 | S | 100 | $292.16 | D | 6,804 | D | |
| Common StockF8 | Feb 17, 2016 | S | 200 | $294.165 | D | 6,604 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF9,F10 | $0.00 | Feb 16, 2016 | M | 267 | D | — | — | Common Stock | 267 | 0 | D |
| Restricted Stock UnitsF11,F10 | $0.00 | Feb 16, 2016 | M | 1,429 | D | — | — | Common Stock | 1,429 | 1,429 | D |
Explanation of responses
- F1Shares were sold pursuant to a 10b5-1 Trading Plan
- F10Restricted Stock Unit award expires upon reporting person's termination of services.
- F11On March 6, 2014, the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain revenue and EBITDA targets for 2014. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 13, 2015, 25% vested on February 15, 2016 and the remaining 25% are scheduled to vest on February 15, 2017, subject solely to continued service.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $284.66 to $285.54, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 and 4 to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $285.77 to $286.32 inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $289.68 to $290.6234 inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $286.92 to $287.6151, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 6, 7 and 8 to this Form 4.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $288.03 to $288.85 inclusive.
- F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $290.05 to $290.63 inclusive.
- F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $294.04 to $294.29 inclusive.
- F9On February 14, 2013, the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain revenue and EBITDA targets for 2013. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 28, 2014, 25% vested on February 15, 2015 and 25% vested on February 15, 2016, subject solely to continued service.